Can a serum bring back fuller brows? a trial investigates

NCT ID NCT07775989

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether a cosmetic eyebrow serum called Dallixa can improve eyebrow fullness in adults with naturally sparse eyebrows (hypotrichosis). Participants will use the serum and be assessed over five months for changes in eyebrow growth, thickness, and density. The study aims to see if the product is both effective and safe for everyday use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a dermo cosmetic eyebrow serum containing herbal or vitamin ingredients
What this could lead to
If effective, this serum could offer a non-invasive way to improve eyebrow fullness in people with naturally sparse eyebrows.
What could go wrong
This is a small, single-arm trial with no placebo group, so results may not be conclusive. As a cosmetic product, effects may be modest and vary between individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

49 people

The number who actually took part.

Started

Aug 2025

Finished

Apr 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Individuals of any sex and at least 18 years of age 2. Subjects who have inadequate eyebrow due to natural causes (eyebrow hypotrichosis) 3. A Grade 1 or 2 on the Global Eyebrow Assessment (GEBA) scale 4. Subjects who agree to forgo any additional treatment to the brows, such as waxing, plucking, threading and/or tinting, laser hair removal, and/or bleaching for the duration of the study. 5. Willing to complete all required study visits, procedures, and evaluations including photography. Exclusion Criteria: 1. Subjects with any uncontrolled systemic disease (like systemic diseases which could prevent hair growth or produce abnormal growth) 2. known diagnoses possibly underlying or contributing to the state of the eyebrows including, but not limited to, telogen effluvium or anagen effluvium 3. Any known diseases, infection or abnormalities to the eyelid or eyebrow (including eczema, seborrheic dermatitis, alopecia areata, trichotillomania, thyroid diseases, atopic dermatitis, history of trauma or burn to the eyebrow region and etc.) 4. Subjects that have thinning brows as a result of over plucking, trichotillomania, chemotherapy or any other condition or treatment that causes hair loss. 5. Patients with permanent eyebrow loss due to over-grooming 6. Allergy to any component of the investigational product 7. Subjects with temporary or semipermanent eyebrow fillers, any permanent or semi-permanent tint, dye or bleaching within 3 months 8. Any skin pigmentation/depigmentation, microblading, tattoos, permanent eye and/or eyebrow make-up, moles, scars, or other characteristics within the eyebrow area 9. Subjects who used permanent injectable fillers in and around the eyebrow area within 12 months 10. Use of any over-the-counter or prescription eyebrow growth product within 3 months 11. Subjects who had undergone any facial surgery (e.g., brow lift) or eyebrow extension within 3 months of screening 12. Current enrollment in an investigational product or device or participation in such a study within 30 days 13. Aphakic subjects and/or pseudophakic subjects with a torn posterior lens capsule 14. Subjects with known risk factors for macular edema 15. Patients with a history of glaucoma and/or increased ocular pressure 16. Patients who are currently using an IOP-lowering prostaglandin analog 17. Previous cosmetic surgery to the upper face (e.g., periorbital surgery, brow lift, eyelid or eyebrow surgery, etc.). 18. Any planned facial cosmetic procedure that would interfere with the evaluation of the eyebrows 19. Participation in another investigational product or device study within the last 30 days 20. Females who are pregnant, nursing, or planning a pregnancy during the study, or who are of childbearing potential and not using a reliable method of contraception

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypotrichosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Akdeniz Üniversitesi Hastanesi

    Antalya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.